tradingkey.logo
搜尋

Propanc Biopharma Ord Shs

PPCB
添加自選
1.941USD
+0.021+1.09%
收盤 11-13 16:00(美東)
2.00M總市值
0.00本益比TTM

關於 Propanc Biopharma Ord Shs 公司

Propanc Biopharma, Inc. is an Australia-based biopharmaceutical company. The Company is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The Company has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.

Propanc Biopharma Ord Shs 簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Propanc Biopharma Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
100.00K
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
33.20K
+75.30%
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
33.20K
+75.30%
Mr. Joseph Himy
Mr. Joseph Himy
Independent Director
Independent Director
33.20K
+75.30%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Mr. James Andrew Nathanielsz
Mr. James Andrew Nathanielsz
Chief Executive Officer, Treasurer, Director
Chief Executive Officer, Treasurer, Director
176.20K
+70.37%
Dr. Julian Norman Kenyon
Dr. Julian Norman Kenyon
Director
Director
100.00K
--
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%
Mr. Josef Zelinger
Mr. Josef Zelinger
Director
Director
41.00K
+60.98%

常見問題

Propanc Biopharma Ord Shs的前五大股東是誰?

Propanc Biopharma Ord Shs的前五大股東如下:Mr. James Andrew Nathanielsz
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有